STAT3 and focal segmental glomerulosclerosis: In focal segmental glomerulosclerosis (FSGS), the JAK–STAT signaling pathway is activated, with increased phosphorylation of STAT1 and STAT3 in both the glomerulus and renal tubulointerstitium [16].